These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis. Higashitani K; Yoshimi R; Sato Y; Watanabe T; Ihata A Mod Rheumatol Case Rep; 2022 Jan; 6(1):87-92. PubMed ID: 34473835 [TBL] [Abstract][Full Text] [Related]
53. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis. Bouiller K; Samson M; Eicher JC; Audia S; Berthier S; Leguy V; Humbert O; Martin L; Lorgis L; Cottin Y; Bonnotte B; Lorcerie B Intern Med J; 2014 Sep; 44(9):928-31. PubMed ID: 25201426 [TBL] [Abstract][Full Text] [Related]
54. Effectiveness of Low-Dose Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Real-Life Experience. Özdel Öztürk B; Yavuz Z; Aydın Ö; Mungan D; Sin BA; Demirel YS; Bavbek S Int Arch Allergy Immunol; 2022; 183(12):1281-1290. PubMed ID: 36126640 [TBL] [Abstract][Full Text] [Related]
55. Familial Eosinophilic Granulomatosis with Polyangiitis in a Sister and Brother. Ueki Y; Oshikata C; Asai Y; Kaneko T; Tsurikisawa N Intern Med; 2020 Apr; 59(7):991-995. PubMed ID: 31813915 [TBL] [Abstract][Full Text] [Related]
56. Onset of eosinophilic granulomatosis with polyangiitis (EGPA) after anti-Th2 biotherapy initiation in severe asthma patients: Report of 3 cases. Fargeas M; Devouassoux G; Gerfaud-Valentin M Respir Med Res; 2024 Jun; 85():101070. PubMed ID: 38141578 [No Abstract] [Full Text] [Related]
57. Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab. Menzella F; Galeone C; Ghidoni G; Ruggiero P; Capobelli S; Simonazzi A; Catellani C; Scelfo C; Livrieri F; Facciolongo N Multidiscip Respir Med; 2021 Jan; 16(1):779. PubMed ID: 34221399 [TBL] [Abstract][Full Text] [Related]
58. Prevalence of Eosinophilic Granulomatosis With Polyangiitis and Associated Health Care Utilization Among Patients With Concomitant Asthma in US Commercial Claims Database. Gokhale M; Bell CF; Doyle S; Fairburn-Beech J; Steinfeld J; Van Dyke MK J Clin Rheumatol; 2021 Apr; 27(3):107-113. PubMed ID: 31693654 [TBL] [Abstract][Full Text] [Related]
59. Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Thiel J; Hässler F; Salzer U; Voll RE; Venhoff N Arthritis Res Ther; 2013 Sep; 15(5):R133. PubMed ID: 24286362 [TBL] [Abstract][Full Text] [Related]
60. Justification of the Subcutaneous Mepolizumab Dose of 300 mg in Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome. Pouliquen IJ; Austin D; Steinfeld J; Yancey SW Clin Ther; 2021 Jul; 43(7):1278-1280. PubMed ID: 34187697 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]